Share this post on:

Product Name :
Acetaminophen/Chlorzoxazone

Search keywords :
Chlorzoxazone

drugId :
null

Target Vo:
Cyclooxygenases

Target Vo Short Name :
COXs

Moa_Name:
Cyclooxygenases inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
null

Origin Company_Name :

Active Company_Name :
Lunan Pharmaceutical Group Co

Active Indication_Name:
Tendon Injuries

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Camrelizumab Autophagy
Bivatuzumab Autophagy
ERK1/2 Antibody: ERK1/2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43/41 kDa, targeting to ERK1/2. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related